Cerus Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cerus Corporation inventory turnover ratio, the Cerus Corporation's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.8 in the first quarter 2026, yet the ratio remained below the average, as CERS's market remain challenging.Average inventory processing period, for the Cerus in Mar 31 2026 quarter, has decreased to 203 days, compare to 207 days, in the Dec 31 2025 quarter.

Within Healthcare sector 224 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1245 in the fourth quarter 2025, to 1366.

CERS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cerus Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CERS Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	26.91 %	47.05 %	45.43 %	50.26 %	20.82 %
Y / Y Cost of Sales Growth	47.06 %	20.83 %	26.32 %	15 %	0 %
Inventory Turnover Ratio (TTM)	1.8	1.76	1.81	1.87	2.01
CERS's Total Ranking	# 1366	# 1245	# 718	# 1199	# 1145
Average inventory processing period	203	208	201	195	182
Seq. Inventory Growth	8.95 %	5.57 %	-2.55 %	13.22 %	26.24 %
Seq. Cost of Sales Growth	-13.79 %	20.83 %	4.35 %	35.29 %	-29.17 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 97
Healthcare Sector	# 225
Overall Market	# 1366

Inventory Turnover Ratio Statistics
High	Average	Low
2.69	1.96	1.46
(Sep 30 2022)		(Sep 30 2017)

CERS Company Profile >> Back to CERS Efficiency Comparisons >> Compare CERS Inventory Turnover Ratio to its Competitors

Financial Statements
Cerus's Inventories	$ 61 Millions	Visit CERS's Balance sheet
Cerus's Cost of Revenues TTM	$ 101 Millions	Visit CERS's Income Statement
What are CERS's Sales?		Visit CERS's Sales by Segment

Other Inventory Turnover Ratios
Cerus's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CERS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CERS's Competitors
Inventory Turnover Ratio for CERS's Suppliers
Inventory Turnover Ratio for CERS's Customers

You may also want to know
CERS's Sales Growth Rates	CERS's Pe Price to earnings ratio	CERS's Receivables Turnover Ratio	CERS's Stock Quote
CERS's Net Income Growth Rates	CERS's Ps Price to Sales ratio	CERS's Sales per Employee	CERS's Asset Turnover Ratio
CERS's Net Margin	CERS's Pb Price to Book ratio	CERS's Financial Strength Ratios	CERS's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Scilex Holding Company	4.48	$ 14.462 Millions	$ 3 Millions
Guardant Health Inc	4.41	$ 379.203 Millions	$ 86 Millions
Idexx Laboratories Inc	4.38	$ 1,690.942 Millions	$ 386 Millions
Envista Holdings Corporation	4.36	$ 1,267.000 Millions	$ 290 Millions
Zai Lab Limited	4.32	$ 190.383 Millions	$ 44 Millions
Inotiv Inc	4.25	$ 175.895 Millions	$ 41 Millions
Cryoport inc	4.23	$ 96.609 Millions	$ 23 Millions
Teva Pharmaceutical Industries Limited	4.22	$ 8,317.000 Millions	$ 1,971 Millions
Incyte Corporation	4.21	$ 403.465 Millions	$ 96 Millions
Electromed Inc	4.16	$ 14.195 Millions	$ 3 Millions
Vericel Corporation	4.15	$ 73.494 Millions	$ 18 Millions
Sharps Technology Inc	4.12	$ 3.585 Millions	$ 1 Millions
Coherus Oncology inc	4.11	$ 14.975 Millions	$ 4 Millions
Novocure Limited	4.08	$ 167.287 Millions	$ 41 Millions
Lifeward ltd	4.08	$ 13.275 Millions	$ 3 Millions
Ge Healthcare Technologies Inc	4.04	$ 9,262.000 Millions	$ 2,294 Millions
Koru Medical Systems Inc	3.99	$ 16.468 Millions	$ 4 Millions
3m Company	3.94	$ 15,087.000 Millions	$ 3,830 Millions
Iridex Corp	3.92	$ 32.247 Millions	$ 8 Millions
Myomo Inc	3.88	$ 14.000 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.84	$ 71.976 Millions	$ 19 Millions
Alpha Teknova Inc	3.79	$ 26.988 Millions	$ 7 Millions
Evolus Inc	3.71	$ 103.000 Millions	$ 28 Millions
Abbvie Inc	3.70	$ 18,420.000 Millions	$ 4,975 Millions
Biocryst Pharmaceuticals Inc	3.67	$ 19.884 Millions	$ 5 Millions
Neuraxis Inc	3.61	$ 0.665 Millions	$ 0 Millions
Mirum Pharmaceuticals Inc	3.50	$ 85.221 Millions	$ 24 Millions
Escalon Medical Corp	3.48	$ 6.698 Millions	$ 2 Millions
Sonoma Pharmaceuticals Inc	3.46	$ 12.114 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.45	$ 461.746 Millions	$ 134 Millions

Date modified: 2026-08-29T17:23:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.